Minnesota Legislative Session Now Underway: MPhA Is Working for Pharmacy at the Capitol
Friday, March 11, 2016
Posted by: Laurie Pumper
The 2016 Minnesota legislative session is now underway! MPhA’s Public Affairs Committee is proactively working on pharmacy-related legislation and working to assure that your interests are represented at the Capitol. Read a summary of legislative activity at the Capitol.
With the extremely short session this year, we are already hearing from legislative Committee Administrators and Committee Chairs that competition for time on committee agendas is fierce and there is not time to hear all bills. We are working with bill authors on strategies to assure that our issues don’t end up on the cutting room floor.
SF 1530/HF 1587 Freedom of Choice for Pharmacy Services
Requires health plans to allow any pharmacy to participate in a network contract, as long as they are willing and able to accept/meet the terms and conditions of the contract.
SF 1530 |
Authors: Hoffman, Metzen, Lourey, Sheran, Rosen.
Status: Passed all relevant Senate committees in 2015, re-referred to Finance Committee this year.
HF 1587 | Authors: Hamilton, Atkins, Davids, Lien.
Status: Referred to Commerce Committee in 2015. No action.
Our primary hurdle with this legislation is getting a hearing in the House Commerce Committee.
SF 2408/HF 2507 Pharmacist Prescribing of Naloxone
Allows pharmacists to prescribe and dispense naloxone.
SF 2408 |
Authors: Eaton, Lourey
HF 2507 | Author: Barrett
No action. (But we believe the prospects for this bill are good.)
SF 2548/HF 2512 Extended Medication Supply
Allows pharmacist to change the quantity on a prescription up to a 90-day supply without contacting the prescriber, as long as there are refills to cover and medication is not a controlled substance.
SF 2548 was introduced by Senator Rosen on March 10.
HF 2512 | Author: R. Peterson
SF 1440/HF 1652 Modifications to the Prescription Monitoring Program
Allows the pharmacist and prescriber to access the PMP in situations other than when considering prescribing or filling a controlled substance prescription. Also allows the Board of Pharmacy to maintain PMP data for a longer period for trend analysis purposes.
SF 1440 | Authors: Rosen, Eaton, Hoffman, Benson, Murphy.
Status: Passed all relevant committees in the Senate in 2015, returned to Judiciary Committee and was passed out of committee, back to the Senate Floor on March 8.
HF 1652 Authors: Baker, Clark.
Status: Passed HHS Reform and Civil Law & Data Practices Committees with several amendments modifying some of the access provisions and the length of time the Board can retain data in 2015. Re-referred (in error) to HHS Reform Committee. Several members of the House have significant concerns about data privacy around this bill. We will fight to maintain the Senate language.
SF 1425/HF 1503 Collection and Disposal of Unused Medications by Pharmacies
Allows pharmacies to implement the DEA’s new rule for disposal of unused medications, including controlled substances, from the public and long-term care facilities.
SF 1425 | Authors: Rosen, Eaton, Hoffman, Benson, Marty.
Status: Passed HHS Policy Committee in the Senate in 2015. Re-referred to HHS Policy. Scheduled to be heard March 11, in HHS Policy Committee.
HF 1503 | Author: Barrett.
Status: Referred to HHS Policy Committee in 2015. No action.
SF 934/HF 1060 Prior Authorizations (From the Minnesota Medical Association)
Places limitations and requirements on PBMs and health plans on circumstances when prior authorization, step therapy, etc., can be placed on a drug and how the process must be handled.
SF 934 | Authors: Franzen, Sheran, Rosen, Metzen, Marty.
Status: Passed HHS Policy, Commerce and State & Local Government Committees. Referred to HHS Finance.
HF 1060 | Authors: Albright, Zerwas, Murphy, E., Gruenhagen, Dean, M., Schoen, Hamilton, Liebling, Uglem, Schultz , Lillie, Dill, Baker, Clark.
Status: Referred to HHS Reform, no action.
CMS released its new 658-page Covered Outpatient Drug Rule in January, outlining how states are to reimburse pharmacies for prescription Drugs. MPhA is reviewing various interpretations of that rule and we have met with Sara Drake, Pharmacy Program Director for Minnesota Department of Human Services, to better understand the impact of that rule on Medicaid reimbursement in Minnesota. Even with 658 pages and an additional seven-page letter to State Medicaid Directors, some areas of the rule remain unclear. Sara Drake was scheduled to have a call with CMS to answer some of her questions during the week of March 7. MPhA will follow up with her.